Showing results (1061-1070 of 1,170) with videos related to
Sort By:
Pageof 117
American Journal of Respiratory and Critical Care Medicine|May 14, 2010
Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility geneCraig P Hersh, Sreekumar G Pillai, Guohua Zhu, et al.Nature Communications|February 16, 2023
Genomics and biochemical analyses reveal a metabolon key to β-L-ODAP biosynthesis in Lathyrus sativusAnne Edwards, Isaac Njaci, Abhimanyu Sarkar, et al.International Journal of Cancer|September 14, 2021
Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practiceMichiel C T van Zeijl, Alfons J M van den Eertwegh, Michel W J M Wouters, et al.Cancers|September 28, 2021
Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort StudyMonique K van der Kooij, Olaf M Dekkers, Maureen J B Aarts, et al.American Journal of Respiratory Cell and Molecular Biology|April 2, 2016
Ablation of Glutaredoxin-1 Modulates House Dust Mite-Induced Allergic Airways Disease in MiceSidra M Hoffman, Xi Qian, James D Nolin, et al.European Journal of Gastroenterology & Hepatology|February 17, 2016
Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasiaJessica Becker, Stefan Niebisch, Arcangelo Ricchiuto, et al.Cancers|November 26, 2022
Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment RegistryDaan Jan Willem Rauwerdink, Remco van Doorn, Jos van der Hage, et al.Journal for Immunotherapy of Cancer|August 6, 2020
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-upJoost H van den Berg, Bianca Heemskerk, Nienke van Rooij, et al.The British Journal of Surgery|June 6, 2025
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trialLiselotte Tas, Marie B Weitemeyer, Maartje W Rohaan, et al.Hepatology International|February 26, 2021
Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patientsMaaike Biewenga, Monique K van der Kooij, Michel W J M Wouters, et al.Pageof 117